1. Home
  2. SILO vs LFLY Comparison

SILO vs LFLY Comparison

Compare SILO & LFLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • LFLY
  • Stock Information
  • Founded
  • SILO 2010
  • LFLY 2010
  • Country
  • SILO United States
  • LFLY United States
  • Employees
  • SILO N/A
  • LFLY N/A
  • Industry
  • SILO Apparel
  • LFLY Computer Software: Prepackaged Software
  • Sector
  • SILO Consumer Discretionary
  • LFLY Technology
  • Exchange
  • SILO Nasdaq
  • LFLY Nasdaq
  • Market Cap
  • SILO 4.7M
  • LFLY 3.9M
  • IPO Year
  • SILO N/A
  • LFLY N/A
  • Fundamental
  • Price
  • SILO $0.84
  • LFLY $1.23
  • Analyst Decision
  • SILO
  • LFLY Strong Buy
  • Analyst Count
  • SILO 0
  • LFLY 2
  • Target Price
  • SILO N/A
  • LFLY $7.59
  • AVG Volume (30 Days)
  • SILO 596.1K
  • LFLY 32.7K
  • Earning Date
  • SILO 11-12-2024
  • LFLY 11-07-2024
  • Dividend Yield
  • SILO N/A
  • LFLY N/A
  • EPS Growth
  • SILO N/A
  • LFLY N/A
  • EPS
  • SILO N/A
  • LFLY N/A
  • Revenue
  • SILO $72,102.00
  • LFLY $35,868,000.00
  • Revenue This Year
  • SILO $1.86
  • LFLY N/A
  • Revenue Next Year
  • SILO N/A
  • LFLY N/A
  • P/E Ratio
  • SILO N/A
  • LFLY N/A
  • Revenue Growth
  • SILO N/A
  • LFLY N/A
  • 52 Week Low
  • SILO $0.77
  • LFLY $1.20
  • 52 Week High
  • SILO $4.50
  • LFLY $5.88
  • Technical
  • Relative Strength Index (RSI)
  • SILO 40.96
  • LFLY 34.88
  • Support Level
  • SILO $0.77
  • LFLY $1.20
  • Resistance Level
  • SILO $0.99
  • LFLY $1.35
  • Average True Range (ATR)
  • SILO 0.10
  • LFLY 0.08
  • MACD
  • SILO 0.00
  • LFLY 0.00
  • Stochastic Oscillator
  • SILO 23.30
  • LFLY 16.92

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About LFLY Leafly Holdings Inc.

Leafly Holdings Inc operates an online cannabis information resource platform. It offers cannabis retailers and brands subscription-based marketplace listings that provide its cannabis audience with information, reviews, menus, and ordering and delivery options through legal retailers.

Share on Social Networks: